Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice - PubMed (original) (raw)
Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice
T Germann et al. Proc Natl Acad Sci U S A. 1995.
Abstract
The induction of arthritis in DBA/1 mice usually requires immunization with the antigen type II collagen emulsified with Mycobacterium tuberculosis in oil. Here we describe that interleukin 12 (IL-12) can replace mycobacteria and cause severe arthritis of DBA/1 mice when administered in combination with type II collagen. Immunization of DBA/1 mice with type II collagen emulsified in oil alone resulted in a weak immune response, and only a few animals (10-30%) developed arthritis. Administration of IL-12 for 5 days simultaneously with each immunization strongly enhanced the anti-type II collagen immune response. Collagen-specific interferon gamma (IFN-gamma) synthesis by ex vivo activated spleen cells was enhanced 3- to 10-fold. IFN-gamma was almost completely produced by CD4+ T cells. Furthermore, the production of collagen-specific IgG2a and IgG2b antibodies was upregulated 10- to 100-fold. As a consequence, the incidence of arthritis in the group of mice immunized with collagen plus IL-12 was very high (80-100%). The developing arthritis was severe, involving approximately 50% of all limbs with strongly increased footpad thickness in most cases. Furthermore, histological examination revealed massive, mainly polymorphonuclear cell infiltration, synovial hyperplasia, cartilage and bone destruction, as well as new bone formation. In many cases, this resulted in the complete loss of joint structure. Neutralization of IFN-gamma in vivo prevented the development of arthritis in collagen-immunized and IL-12-treated mice. In conclusion, our data show that in vivo administered IL-12 can profoundly upregulate a T helper I-type autoimmune response, resulting in severe joint disease in DBA/1 mice.
Similar articles
- Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
Germann T, Hess H, Szeliga J, Rüde E. Germann T, et al. Ann N Y Acad Sci. 1996 Oct 31;795:227-40. doi: 10.1111/j.1749-6632.1996.tb52672.x. Ann N Y Acad Sci. 1996. PMID: 8958934 - IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
Szeliga J, Hess H, Rüde E, Schmitt E, Germann T. Szeliga J, et al. Int Immunol. 1996 Aug;8(8):1221-7. doi: 10.1093/intimm/8.8.1221. Int Immunol. 1996. PMID: 8918691 - Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Joosten LA, et al. Arthritis Res. 1999;1(1):81-91. doi: 10.1186/ar14. Epub 1999 Oct 26. Arthritis Res. 1999. PMID: 11056663 Free PMC article. - Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB. Chu CQ, et al. Arthritis Rheum. 2007 Apr;56(4):1145-51. doi: 10.1002/art.22453. Arthritis Rheum. 2007. PMID: 17393396 - Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY. Min SY, et al. Arthritis Res Ther. 2004;6(3):R213-9. doi: 10.1186/ar1169. Epub 2004 Mar 11. Arthritis Res Ther. 2004. PMID: 15142267 Free PMC article.
Cited by
- Elevated expression of interleukin-27, IL-35, and decreased IL-12 in patients with thyroid-associated ophthalmopathy.
Zhang P, Zhang X, Xu F, Xu W, Zhu H. Zhang P, et al. Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):1091-1100. doi: 10.1007/s00417-022-05856-7. Epub 2022 Nov 12. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36370169 - A novel cytokine consisting of the p40 and EBI3 subunits suppresses experimental autoimmune arthritis via reciprocal regulation of Th17 and Treg cells.
Lee SY, Moon SJ, Moon YM, Seo HB, Ryu JG, Lee AR, Lee CR, Kim DS, Her YM, Choi JW, Kwok SK, Park SH, Cho ML. Lee SY, et al. Cell Mol Immunol. 2022 Jan;19(1):79-91. doi: 10.1038/s41423-021-00798-2. Epub 2021 Nov 15. Cell Mol Immunol. 2022. PMID: 34782759 Free PMC article. - The Potential Role of Schistosome-Associated Factors as Therapeutic Modulators of the Immune System.
Li J, Liu H, Jiang J, She X, Niu Y, Ming Y. Li J, et al. Infect Immun. 2020 Jul 21;88(8):e00754-19. doi: 10.1128/IAI.00754-19. Print 2020 Jul 21. Infect Immun. 2020. PMID: 32341115 Free PMC article. Review. - Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis.
Liu F, Cheng W, Pappoe F, Hu X, Wen H, Luo Q, Wang S, Deng F, Xie Y, Xu Y, Shen J. Liu F, et al. Parasitol Res. 2016 Oct;115(10):3795-806. doi: 10.1007/s00436-016-5140-0. Epub 2016 Jul 8. Parasitol Res. 2016. PMID: 27393379 - Possible roles of IL-12-family cytokines in rheumatoid arthritis.
Pope RM, Shahrara S. Pope RM, et al. Nat Rev Rheumatol. 2013 Apr;9(4):252-6. doi: 10.1038/nrrheum.2012.170. Epub 2012 Oct 23. Nat Rev Rheumatol. 2013. PMID: 23090510 Free PMC article. Review.
References
- J Immunol. 1983 Nov;131(5):2178-83 - PubMed
- Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784-8 - PubMed
- J Exp Med. 1985 Dec 1;162(6):1878-91 - PubMed
- Arthritis Rheum. 1986 Mar;29(3):400-10 - PubMed
- Science. 1987 May 22;236(4804):944-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials